Impact of the number of cryopreserved CD34 + cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study.

Partanen AnuAntti TurunenRaija SilvennoinenJaakko ValtolaMarja PyöräläTimo SiitonenAnu SikiöMervi PutkonenMarja SankeloKarri PenttiläTaru KuittinenPentti MäntymaaJukka PelkonenEsa JantunenVille Varmavuo

Published in: Journal of clinical apheresis (2022)

cells did not affect PFS or OS.

Keyphrases

stem cell transplantation
induced apoptosis
cell cycle arrest
newly diagnosed
high dose
end stage renal disease
ejection fraction
patient reported outcomes
mesenchymal stem cells
cell therapy
multiple myeloma